UCSF

Burchard elected to ASCI

Esteban G. Burchard, MD, MPH, was elected in spring 2009 to the American Society of Clinical Investigation (ASCI). Established in 1908, the ASCI is one of the oldest medical honor societies in the US. More than 2,800 physician-scientists from all medical specialties are elected members of the Society based upon their records of achievement in biomedical research.

Burchard is as associate professor in the Department of Bioengineering and Therapeutic Sciences, which is a joint department of the UCSF Schools of Pharmacy and Medicine. His research focuses on identifying genetic risk factors for asthma in ethnically diverse populations. He is an international leader in the genetic epidemiology of diseases in minority populations. In addition, he co-directs the UCSF/San Francisco General Hospital Medical Center's DNA Banking Facility.

Burchard earned an MD from the Stanford University School of Medicine and completed clinical training in internal medicine at Harvard University's Brigham and Women's Hospital. He received pulmonary/critical care medicine training at UCSF. Burchard also completed clinical research training at the Harvard School of Public Health. He joined the UCSF faculty in 2001.

Tags

Sites:
School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.